These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Author: Ostensen ME, Thiele DL, Lipsky PE.
    Journal: J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514.
    Abstract:
    The current studies examined the potential for additive or synergistic augmentation of human natural killer (NK) function by combined stimulation with tumor necrosis factor alpha (TNF-alpha) or interleukin-1 (IL-1) and interferon-alpha (IFN-alpha) or IL-2. The modest augmentative effect of preincubation with either IL-1 or TNF-alpha alone was most consistently shown when killing of an NK-resistant target was examined. Preincubation with the combination of IL-1 and TNF-alpha caused no additive effect on NK function. Following preincubation with IL-1 and IL-2 or TNF-alpha and IL-2, marked enhancement of NK activity was noted, particularly when lysis of the NK-resistant target Cur was assessed. Killing of K562 targets was more markedly augmented by costimulation with TNF-alpha and IL-2 than with IL-2 alone or the combination of IL-1 and IL-2. Finally, IFN-alpha in combination with either TNF-alpha or IL-1 markedly enhanced Cur lysis, whereas interferon-gamma failed to augment IL-1- or TNF-alpha-enhanced tumor lysis. These findings demonstrate the separate and cooperative effects on human NK function of TNF-alpha or IL-1 in combination with IL-2 or IFN-alpha and suggest that the appropriate combinations of such agents may serve as the basis for in vivo multiagent immunotherapeutic regimens.
    [Abstract] [Full Text] [Related] [New Search]